Updates are available Correction dated 2023-11-09
Click to view Correction: https://doi.org/10.1186/s13024-023-00678-5
-
Authors
Alam, John J. http://orcid.org/0000-0002-1285-1115
Nixon, Ralph A.
- License Information
-
More Information
Article History
Received: 15 September 2023
Accepted: 29 September 2023
First Online: 4 October 2023
Change Date: 9 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13024-023-00678-5
Declarations
:
: Not applicable (referenced clinical study was conducted according to Declaration of Helsinki and consent was obtained in all study participants in that study).
: Not applicable.
: JA is an employee of CervoMed, a commercial enterprise developing neflamapimod as a treatment for DLB.
